Homogeneous nonisotopic assay for phenytoin evaluated

Area of Science:

• Clinical Chemistry
• Analytical Chemistry
• Immunochemistry

Background:

• Phenytoin is an anticonvulsant medication requiring therapeutic drug monitoring.
• Accurate and efficient assays are crucial for optimizing phenytoin dosage and patient outcomes.
• Existing methods may require sample pretreatment or dilution, adding complexity.

Purpose of the Study:

• To evaluate a novel homogeneous immunoprecipitation assay for quantifying phenytoin in human serum.
• To assess the assay's performance characteristics, including accuracy, precision, and comparison to existing methods.

Main Methods:

• Development of a homogeneous immunoprecipitation assay utilizing spectrophotometry.
• The assay measures the inhibition of a precipitation reaction by free phenytoin.
• Automated analysis performed using a centrifugal analyzer with a 3-minute reaction monitoring time.

Main Results:

• The assay requires no sample dilution or pretreatment.
• Excellent precision was demonstrated with within-run and between-run coefficients of variation below 7%.
• Results correlated well with a standard enzyme immunoassay (y = 1.10x + 1.1, r = 0.966).

Conclusions:

• The novel homogeneous immunoprecipitation assay provides a rapid, accurate, and precise method for phenytoin determination in human serum.
• This assay simplifies the analytical process by eliminating the need for sample preparation.
• It represents a valuable tool for therapeutic drug monitoring of phenytoin.